Open in interactive viewer → charts, metric popovers & call review

Qualys Sold the AI Security Story. The Billings Guide Is Still 8%.

A federal-heavy beat, a flat 105% expansion rate, and a remediation product that has yet to change the P&L
QLYS · Earnings Call · 2026-11-09

The Flood Is Real; the Financial Inflection Is Not

Qualys reported a quarter that looked, at first glance, like the AI-security inflection finally arriving. Revenue rose 11% to $188 million, EPS came in at $2.12, and adjusted EBITDA margin held at 48%. Current calculated billings grew 14%, following 16% in Q2. Management also raised full-year EPS guidance to $8.07–$8.14 from $7.74–$7.88. But the details tell a more complicated story: the billings beats were sourced from two narrow, lumpy events, not a broad re-rating of the installed base. The backdrop is not hype. The broader market has been consumed by Frontier AI, and Qualys is riding the security subset of that wave. On the call, Sumedh Thakar framed the shift in stark numbers: “Microsoft’s recent Patch Tuesday disclosed 1,414 new vulnerabilities in a single release compared to 93 before the advent of Frontier AI.” — Sumedh Thakar, President and Chief Executive Officer · 2026-11-09 That is a 15-fold increase in exposure volume in seven months, by management’s math. The old detect-and-ticket workflow cannot absorb it, which is why Qualys is pushing autonomous exploitation validation and remediation rather than another dashboard. The new product is True Confidence, a remediation orchestration engine that checks existing third-party controls before a fix is raised, extends coverage to agentless assets, and monitors whether a patch actually held. The pitch is simple: fix the minimum, prove closure, and do it without an outage. The proof points are real: Agent Insta detects newly exposed systems in under 60 minutes; Agent Val has run roughly 9 million exploit validations and found only 11% exploitable; TrueRisk Eliminate has deployed 180 million patches in the last 12 months, 60% autonomously, with a rollback rate below 1 in 8,000. This is the most credible part of the story: Qualys is no longer just counting the number of CVEs; it is selling operational confidence.

The Beat Was Federal; the Guide Is 8%

But the financials do not yet confirm a broad enterprise inflection. Revenue grew 11%, and Q3’s billings beat came primarily from the federal business. CFO Joo Mi Kim was unusually direct about the source and the risk: “Revenues grew 11% to $188 million.” — Joo Mi Kim, Chief Financial Officer · 2026-11-09 Then, on the Q4 billings outlook, she said what the model is really assuming: “really a healthy 8% is approximately what we’re expecting for Q4 calculated current billings.” — Joo Mi Kim, Chief Financial Officer · 2026-11-09 That is a sharp step down from the 14% and 16% prints of the prior two quarters.

I think it’s more of the latter. ... the base case remains, of course, where we don’t see a significant change in the net dollar expansion rate, which is our key KPI.

Joo Mi Kim, Chief Financial Officer · 2026-11-09
The key KPI is still 105%, unchanged from last quarter. The ETM/CSAM customer cohort improved to 108% from 107%, but that is a narrow slice. The channel now represents 55% of revenue and grew 24%, offsetting a 2% decline in direct; international growth was ahead of a domestic business that grew 7%. QFlex, the flexible consumption model, had its first full quarter and customers increased average annual bookings by over 20%, but management cautioned the cohort is too small to extrapolate. In other words, the mix is improving at the edges while the core expansion rate stays flat. The pattern repeats prior calls. In August, Thakar said post-Mythos had helped accelerate a couple of opportunities, but “we already had a few customers in the pipeline who were discussing with this, who saw this beforehand.” — Sumedh Thakar, President and CEO · 2026-08-04 In May, on the same AI-driven demand question, he cautioned it was “a little too early right now to talk about how the impact is going to be on the pipeline and outlook.” — Sumedh Thakar, President and Chief Executive Officer · 2026-05-05 And in February, on net dollar expansion, Kim said Qualys did not anticipate “a material change to that rate.” — Joo Mi Kim, Chief Financial Officer · 2026-02-05 Three quarters later, that is still the base case.

What the Tape Believes

Investors have been willing to pay for the product story ahead of the P&L. The stock is up 28% over the last 90 trading days and peaked at $230.29 on October 29; as of November 9 it sits 12% below that high. The market had priced an acceleration that guidance does not contain. Yet the valuation is not stretched versus history: 6.8x price-to-revenue compares with a 2020 peak of 13.2x. The operating model is also powerful: 36.8% operating margin and $182M of revenue, up 11% year over year. If autonomous remediation becomes standard, the incremental margins are high. But the evidence so far is product traction, not a P&L inflection.

The Tell: What Management Stopped Emphasizing

One subtle shift is in the language. MROC partners remain part of the go-to-market story, but partner-led acceleration is still framed as a multi-quarter build. QFlex, which was a fresh priority in prior calls, did not make the top-30 keyword list this quarter even as management cited its 20% bookings uplift—suggesting the market’s attention has moved to the remediation narrative. Meanwhile, vulnerability management remains central, but as a workflow, not a scanner. On competition, Thakar was blunt: “less conversations about how many CVEs are you detecting, more about... are you able to detect them fast than competing solutions which are taking 2 to 3 days for scanning.” — Sumedh Thakar, President and Chief Executive Officer · 2026-11-09 He also warned that customers do not show a knee-jerk reaction to celebrity vulnerabilities: “we don’t see that knee-jerk reaction immediately.” — Sumedh Thakar, President and Chief Executive Officer · 2026-11-09 The story is not that Qualys is losing. It is that the market wants proof of a second derivative. Qualys has built the product—autonomous REMOps with true confidence—and a federal beachhead. It has not yet shown that the broader enterprise base will pay for autonomous remediation at a pace that changes 10% revenue growth and a 105% net dollar expansion rate. Until that happens, the stock is a show-me story with powerful optionality, and the Q4 billings guide is the number that matters most.